🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 30 Days
›
Biotechnology Industry
Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(1094)
All (1094)
Buys (90)
Sells (1004)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 20, 2026
Sale
Shares
660
Price
$526.06
Total Value
$347.20K
Shares Held After
42,691
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 20, 2026
Sale
Shares
1,815
Price
$525.02
Total Value
$952.91K
Shares Held After
43,351
% of Holdings
4.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 20, 2026
Sale
Shares
2,749
Price
$524.18
Total Value
$1.44M
Shares Held After
45,166
% of Holdings
5.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 20, 2026
Sale
Shares
1,538
Price
$523.28
Total Value
$804.81K
Shares Held After
47,915
% of Holdings
3.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 20, 2026
Sale
Shares
520
Price
$521.69
Total Value
$271.28K
Shares Held After
49,453
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 20, 2026
Sale
Shares
40
Price
$520.34
Total Value
$20.81K
Shares Held After
49,973
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Maze Therapeutics, Inc.
(MAZE)
Bernstein Harold
— President, R&D & CMO
Mar 20, 2026
Sale
Shares
5,044
Price
$50.02
Total Value
$252.29K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Maze Therapeutics, Inc.
(MAZE)
Bernstein Harold
— President, R&D & CMO
Mar 20, 2026
Sale
Shares
3,795
Price
$49.32
Total Value
$187.17K
Shares Held After
5,044
% of Holdings
42.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Maze Therapeutics, Inc.
(MAZE)
Bernstein Harold
— President, R&D & CMO
Mar 20, 2026
Sale
Shares
6,161
Price
$48.20
Total Value
$296.98K
Shares Held After
8,839
% of Holdings
41.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Esposito Pamela
— Director
Mar 20, 2026
Sale
Shares
1,200
Price
$79.94
Total Value
$95.93K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Esposito Pamela
— Director
Mar 20, 2026
Sale
Shares
600
Price
$79.24
Total Value
$47.55K
Shares Held After
1,200
% of Holdings
33.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Esposito Pamela
— Director
Mar 20, 2026
Sale
Shares
700
Price
$77.71
Total Value
$54.40K
Shares Held After
1,800
% of Holdings
28.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Bicara Therapeutics Inc.
(BCAX)
Mazumdar Claire
— Director
Mar 20, 2026
Sale
Shares
1,596
Price
$18.95
Total Value
$30.25K
Shares Held After
339,392
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 501–550 of 1094 transactions (page 11 of 22)
Version: v26.3.33